Email updates

Keep up to date with the latest news and content from BMC Medicine and BioMed Central.

Journal App

google play app store
Open Access Commentary

Do statins lower testosterone and does it matter?

Allan D Sniderman* and George Thanassoulis

Author Affiliations

Division of Cardiology, McGill University Health Centre, 687 Pine Avenue West, Montreal, QC H3A 1A1, Canada

For all author emails, please log on.

BMC Medicine 2013, 11:58  doi:10.1186/1741-7015-11-58

Published: 28 February 2013

Abstract

Drugs are two-sided swords and statins are no exception. Schooling et al. demonstrate that, on average, statins produce small, but statistically significant, decreases in testosterone. They appropriately emphasize that the clinical significance of their observations is unclear but suggest that changes in testosterone might be related to the benefits of therapy as well as the risks, such as the increased chance of diabetes mellitus. Their findings and hypotheses are noteworthy. However, we believe this represents another example of the limitations in the published summaries of drug effects. How do we know all changes induced by drugs are normally distributed? Some may be affected much more than others. Moreover, the confidence intervals of a meta-analysis describe the variance of the mean effect, not the range of effects, and while the mean change characterizes the impact of a drug on a group of patients, the range more fully characterizes its effects on individuals. We treat individuals not groups. Averages do not disclose enough about the risks and benefits of drugs.

See related research article here http://www.biomedcentral.com/1741-7015/11/57 webcite

Keywords:
statins; testosterone; drug side effects